Tags

Type your tag names separated by a space and hit enter

Considerations for Assessing Risk of Provider Exposure to SARS-CoV-2 after a Negative Test.
Anesthesiology. 2020 08; 133(2):483-485.A

Authors+Show Affiliations

University of Washington, Seattle, Washington (W.V.C.). vancleve@uw.edu.No affiliation info availableNo affiliation info available

Pub Type(s)

Letter

Language

eng

PubMed ID

32404774

Citation

Long, Dustin R., et al. "Considerations for Assessing Risk of Provider Exposure to SARS-CoV-2 After a Negative Test." Anesthesiology, vol. 133, no. 2, 2020, pp. 483-485.
Long DR, Sunshine JE, Van Cleve W. Considerations for Assessing Risk of Provider Exposure to SARS-CoV-2 after a Negative Test. Anesthesiology. 2020;133(2):483-485.
Long, D. R., Sunshine, J. E., & Van Cleve, W. (2020). Considerations for Assessing Risk of Provider Exposure to SARS-CoV-2 after a Negative Test. Anesthesiology, 133(2), 483-485. https://doi.org/10.1097/ALN.0000000000003392
Long DR, Sunshine JE, Van Cleve W. Considerations for Assessing Risk of Provider Exposure to SARS-CoV-2 After a Negative Test. Anesthesiology. 2020;133(2):483-485. PubMed PMID: 32404774.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Considerations for Assessing Risk of Provider Exposure to SARS-CoV-2 after a Negative Test. AU - Long,Dustin R, AU - Sunshine,Jacob E, AU - Van Cleve,Wil, PY - 2020/5/15/pubmed PY - 2020/7/25/medline PY - 2020/5/15/entrez SP - 483 EP - 485 JF - Anesthesiology JO - Anesthesiology VL - 133 IS - 2 SN - 1528-1175 UR - https://www.unboundmedicine.com/medline/citation/32404774/Considerations_for_Assessing_Risk_of_Provider_Exposure_to_SARS_CoV_2_after_a_Negative_Test_ L2 - https://pubs.asahq.org/anesthesiology/article-lookup/doi/10.1097/ALN.0000000000003392 DB - PRIME DP - Unbound Medicine ER -